{"id":"https://openalex.org/W7203685513","doi":"https://doi.org/10.1155/padi/5349481","title":"Parkinson\u2019s Disease: Immunometabolic Control Points Across Neural, Vascular, and Peripheral Systems","display_name":"Parkinson\u2019s Disease: Immunometabolic Control Points Across Neural, Vascular, and Peripheral Systems","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7203685513","doi":"https://doi.org/10.1155/padi/5349481","pmid":"https://pubmed.ncbi.nlm.nih.gov/42614481","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13481713"},"language":"en","primary_location":{"id":"doi:10.1155/padi/5349481","doi":"https://doi.org/10.1155/padi/5349481","is_oa":true,"landing_page_url":"https://doi.org/10.1155/padi/5349481","pdf_url":null,"source":{"id":"https://openalex.org/S191738791","display_name":"Parkinson s Disease","issn_l":"2042-0080","issn":["2042-0080","2090-8083"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Parkinson's Disease","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1155/padi/5349481","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5120158131","display_name":"Felix Narvaez Irizarry","orcid":"https://orcid.org/0009-0001-5388-4327","observed_orcids":["https://orcid.org/0009-0001-5388-4327"]},"institutions":[{"id":"https://openalex.org/I201879955","display_name":"Central University of the Caribbean","ror":"https://ror.org/01rpmzy83","country_code":"PR","type":"education","lineage":["https://openalex.org/I201879955"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Felix Y. Narvaez Irizarry","raw_affiliation_strings":["Universidad Central del Caribe (UCC), Bayam\u00f3n 00960, Puerto Rico, USA"],"raw_orcid":"https://orcid.org/0009-0001-5388-4327","affiliations":[{"raw_affiliation_string":"Universidad Central del Caribe (UCC), Bayam\u00f3n 00960, Puerto Rico, USA","institution_ids":["https://openalex.org/I201879955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132853454","display_name":"Alondra M. Bermudez Adorno","orcid":"https://orcid.org/0009-0002-1225-6727","observed_orcids":["https://orcid.org/0009-0002-1225-6727"]},"institutions":[{"id":"https://openalex.org/I201879955","display_name":"Central University of the Caribbean","ror":"https://ror.org/01rpmzy83","country_code":"PR","type":"education","lineage":["https://openalex.org/I201879955"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Alondra M. Bermudez Adorno","raw_affiliation_strings":["Universidad Central del Caribe (UCC), Bayam\u00f3n 00960, Puerto Rico, USA"],"raw_orcid":"https://orcid.org/0009-0002-1225-6727","affiliations":[{"raw_affiliation_string":"Universidad Central del Caribe (UCC), Bayam\u00f3n 00960, Puerto Rico, USA","institution_ids":["https://openalex.org/I201879955"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015281204","display_name":"Boris S. Ermolinsky","orcid":"https://orcid.org/0000-0002-8981-5630","observed_orcids":["https://orcid.org/0000-0002-8981-5630"]},"institutions":[{"id":"https://openalex.org/I2802326326","display_name":"The University of Texas Rio Grande Valley","ror":"https://ror.org/02p5xjf12","country_code":"US","type":"education","lineage":["https://openalex.org/I2802326326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Boris Ermolinsky","raw_affiliation_strings":["University of Texas Rio Grande Valley (UTRGV), Brownsville 78539, Texas, USA"],"raw_orcid":"https://orcid.org/0000-0002-8981-5630","affiliations":[{"raw_affiliation_string":"University of Texas Rio Grande Valley (UTRGV), Brownsville 78539, Texas, USA","institution_ids":["https://openalex.org/I2802326326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026515370","display_name":"Lilia Y. Kucheryavykh","orcid":"https://orcid.org/0000-0001-8053-5619","observed_orcids":["https://orcid.org/0000-0001-8053-5619"]},"institutions":[{"id":"https://openalex.org/I201879955","display_name":"Central University of the Caribbean","ror":"https://ror.org/01rpmzy83","country_code":"PR","type":"education","lineage":["https://openalex.org/I201879955"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Lilia Kucheryavykh","raw_affiliation_strings":["Universidad Central del Caribe (UCC), Bayam\u00f3n 00960, Puerto Rico, USA"],"raw_orcid":"https://orcid.org/0000-0001-8053-5619","affiliations":[{"raw_affiliation_string":"Universidad Central del Caribe (UCC), Bayam\u00f3n 00960, Puerto Rico, USA","institution_ids":["https://openalex.org/I201879955"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066723639","display_name":"Mikhail Y. Inyushin","orcid":"https://orcid.org/0000-0003-3253-7307","observed_orcids":["https://orcid.org/0000-0003-3253-7307"]},"institutions":[{"id":"https://openalex.org/I201879955","display_name":"Central University of the Caribbean","ror":"https://ror.org/01rpmzy83","country_code":"PR","type":"education","lineage":["https://openalex.org/I201879955"]}],"countries":["PR"],"is_corresponding":true,"raw_author_name":"Mikhail Inyushin","raw_affiliation_strings":["Universidad Central del Caribe (UCC), Bayam\u00f3n 00960, Puerto Rico, USA"],"raw_orcid":"https://orcid.org/0000-0003-3253-7307","affiliations":[{"raw_affiliation_string":"Universidad Central del Caribe (UCC), Bayam\u00f3n 00960, Puerto Rico, USA","institution_ids":["https://openalex.org/I201879955"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5066723639"],"corresponding_institution_ids":["https://openalex.org/I201879955"],"apc_list":{"value":2160,"currency":"USD","value_usd":2160},"apc_paid":{"value":2160,"currency":"USD","value_usd":2160},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.45020053,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2026","issue":"1","first_page":"5349481","last_page":"5349481"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.027799999341368675,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunometabolism","display_name":"immunometabolism","score":0.921999990940094},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/gut-brain-axis","display_name":"gut-brain axis","score":0.9440000057220459},{"id":"https://openalex.org/keywords/platelet-activation","display_name":"platelet activation","score":0.8569999933242798},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.9629999995231628},{"id":"https://openalex.org/keywords/pd-1-pd-l1-axis","display_name":"PD-1/PD-L1 axis","score":0.906000018119812},{"id":"https://openalex.org/keywords/visfatin","display_name":"visfatin","score":0.7329999804496765},{"id":"https://openalex.org/keywords/basal-ganglia-dysfunction","display_name":"basal ganglia dysfunction","score":0.7179999947547913},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6740000247955322},{"id":"https://openalex.org/keywords/dopaminergic-neuron-degeneration","display_name":"dopaminergic neuron loss","score":0.6899999976158142},{"id":"https://openalex.org/keywords/non-motor-symptoms","display_name":"non-motor symptoms","score":0.7459999918937683},{"id":"https://openalex.org/keywords/metabolic-intervention","display_name":"metabolic intervention","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6883000135421753},{"id":"https://openalex.org/C87753298","wikidata":"https://www.wikidata.org/wiki/Q17157137","display_name":"Neuroinflammation","level":3,"score":0.6477000117301941},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.6347000002861023},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6258999705314636},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5961999893188477},{"id":"https://openalex.org/C2776525014","wikidata":"https://www.wikidata.org/wiki/Q1531991","display_name":"Parkinsonism","level":3,"score":0.5292999744415283},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.5199999809265137},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.4977000057697296},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.492000013589859},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.46389999985694885},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4350999891757965},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4066999852657318},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.38499999046325684},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.3578000068664551},{"id":"https://openalex.org/C2776773494","wikidata":"https://www.wikidata.org/wiki/Q3366041","display_name":"Pars compacta","level":5,"score":0.32499998807907104},{"id":"https://openalex.org/C2780391879","wikidata":"https://www.wikidata.org/wiki/Q18035058","display_name":"Nicotinamide phosphoribosyltransferase","level":4,"score":0.320499986410141},{"id":"https://openalex.org/C2776286997","wikidata":"https://www.wikidata.org/wiki/Q2880966","display_name":"Dopaminergic pathways","level":4,"score":0.30979999899864197},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.29910001158714294},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.28839999437332153},{"id":"https://openalex.org/C2776252253","wikidata":"https://www.wikidata.org/wiki/Q7663815","display_name":"Systemic inflammation","level":3,"score":0.27480000257492065},{"id":"https://openalex.org/C2777209026","wikidata":"https://www.wikidata.org/wiki/Q412405","display_name":"Inflammasome","level":3,"score":0.2694000005722046},{"id":"https://openalex.org/C2776355744","wikidata":"https://www.wikidata.org/wiki/Q4318555","display_name":"Nigrostriatal pathway","level":5,"score":0.2671999931335449},{"id":"https://openalex.org/C2984863031","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Cognitive decline","level":4,"score":0.26589998602867126},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2646999955177307},{"id":"https://openalex.org/C2780194698","wikidata":"https://www.wikidata.org/wiki/Q6005429","display_name":"Immune dysregulation","level":3,"score":0.26269999146461487}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1155/padi/5349481","doi":"https://doi.org/10.1155/padi/5349481","is_oa":true,"landing_page_url":"https://doi.org/10.1155/padi/5349481","pdf_url":null,"source":{"id":"https://openalex.org/S191738791","display_name":"Parkinson s Disease","issn_l":"2042-0080","issn":["2042-0080","2090-8083"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Parkinson's Disease","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13481713","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13481713/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13481713/pdf/PADI-2026-5349481.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Parkinsons Dis","raw_type":"Text"},{"id":"pmid:42614481","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42614481","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Parkinson's disease","raw_type":"Journal Article"},{"id":"pmh:oai:scholarworks.utrgv.edu:ibcs_fac-1160","doi":null,"is_oa":true,"landing_page_url":"https://scholarworks.utrgv.edu/ibcs_fac/162","pdf_url":"https://scholarworks.utrgv.edu/cgi/viewcontent.cgi?article=1160&context=ibcs_fac","source":{"id":"https://openalex.org/S4306402611","display_name":"ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2802326326","host_organization_name":"The University of Texas Rio Grande Valley","host_organization_lineage":["https://openalex.org/I2802326326"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"School of Integrative Biological & Chemical Sciences Faculty Publications","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:fc1a9a1ec9214a709a3dd02f96c33494","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/fc1a9a1ec9214a709a3dd02f96c33494","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Parkinson's Disease, Vol 2026 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1155/padi/5349481","doi":"https://doi.org/10.1155/padi/5349481","is_oa":true,"landing_page_url":"https://doi.org/10.1155/padi/5349481","pdf_url":null,"source":{"id":"https://openalex.org/S191738791","display_name":"Parkinson s Disease","issn_l":"2042-0080","issn":["2042-0080","2090-8083"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319869","host_organization_name":"Hindawi Publishing Corporation","host_organization_lineage":["https://openalex.org/P4310319869","https://openalex.org/P4310320595"],"host_organization_lineage_names":["Hindawi Publishing Corporation","Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Parkinson's Disease","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G4086276731","display_name":"Pyk2 regulates extracellular vesicles release in GBM cells and modulates activation of tumor infiltrating myeloid cells","funder_award_id":"1r15ca287203-01","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7060096540","display_name":"Pyk2 inhibition mitigates immunosuppressive environment and enhances therapeutic response to immune checkpoint inhibitors in GBM","funder_award_id":"1r16gm153522-01","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000872253","display_name":"Build-up of beta-amyloid in the brain in Parkinson's disease","funder_award_id":"SC3GM143983","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G9000873498","display_name":"Alliance for Clinical and Translational Research (Alliance)","funder_award_id":"P50GM133807","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":132,"referenced_works":["https://openalex.org/W1506367734","https://openalex.org/W1528957228","https://openalex.org/W1580441010","https://openalex.org/W1598029032","https://openalex.org/W1631356348","https://openalex.org/W1768846296","https://openalex.org/W1920030402","https://openalex.org/W1959721425","https://openalex.org/W1970577444","https://openalex.org/W1975391500","https://openalex.org/W1975774284","https://openalex.org/W1980825524","https://openalex.org/W1981458288","https://openalex.org/W1986611577","https://openalex.org/W1987380827","https://openalex.org/W1987764203","https://openalex.org/W1990341278","https://openalex.org/W1991842902","https://openalex.org/W1993686673","https://openalex.org/W2005263534","https://openalex.org/W2006035554","https://openalex.org/W2007634950","https://openalex.org/W2016722329","https://openalex.org/W2018822471","https://openalex.org/W2021728607","https://openalex.org/W2024486693","https://openalex.org/W2040042139","https://openalex.org/W2044700058","https://openalex.org/W2052742260","https://openalex.org/W2060588252","https://openalex.org/W2064996887","https://openalex.org/W2066120788","https://openalex.org/W2073449985","https://openalex.org/W2074191835","https://openalex.org/W2079402113","https://openalex.org/W2080225612","https://openalex.org/W2093301541","https://openalex.org/W2106022949","https://openalex.org/W2108629610","https://openalex.org/W2109001751","https://openalex.org/W2110457518","https://openalex.org/W2110815409","https://openalex.org/W2111464898","https://openalex.org/W2118804183","https://openalex.org/W2124236172","https://openalex.org/W2132894148","https://openalex.org/W2146264128","https://openalex.org/W2151283331","https://openalex.org/W2155395152","https://openalex.org/W2156411508","https://openalex.org/W2163870492","https://openalex.org/W2284984697","https://openalex.org/W2402724338","https://openalex.org/W2407359553","https://openalex.org/W2525903933","https://openalex.org/W2531587677","https://openalex.org/W2737555531","https://openalex.org/W2743583038","https://openalex.org/W2761586559","https://openalex.org/W2765936263","https://openalex.org/W2784164089","https://openalex.org/W2791055386","https://openalex.org/W2791758888","https://openalex.org/W2807106907","https://openalex.org/W2885227302","https://openalex.org/W2893696361","https://openalex.org/W2899031631","https://openalex.org/W2899141531","https://openalex.org/W2901548714","https://openalex.org/W2927566991","https://openalex.org/W2940810421","https://openalex.org/W2952801565","https://openalex.org/W2954390789","https://openalex.org/W2961254431","https://openalex.org/W2963580194","https://openalex.org/W2969956278","https://openalex.org/W2977367243","https://openalex.org/W3006150521","https://openalex.org/W3008757165","https://openalex.org/W3042654062","https://openalex.org/W3080436335","https://openalex.org/W3093436856","https://openalex.org/W3100272746","https://openalex.org/W3107060429","https://openalex.org/W3112561953","https://openalex.org/W3115773653","https://openalex.org/W3123620074","https://openalex.org/W3135161880","https://openalex.org/W3159676560","https://openalex.org/W3205332524","https://openalex.org/W3214124425","https://openalex.org/W3214770882","https://openalex.org/W4211044101","https://openalex.org/W4211123396","https://openalex.org/W4214689898","https://openalex.org/W4214833982","https://openalex.org/W4220988176","https://openalex.org/W4225332040","https://openalex.org/W4226076555","https://openalex.org/W4241279990","https://openalex.org/W4281714599","https://openalex.org/W4283016791","https://openalex.org/W4295540029","https://openalex.org/W4295756773","https://openalex.org/W4361010653","https://openalex.org/W4361267272","https://openalex.org/W4366452046","https://openalex.org/W4375855765","https://openalex.org/W4385665939","https://openalex.org/W4386143003","https://openalex.org/W4386578879","https://openalex.org/W4388759586","https://openalex.org/W4389233067","https://openalex.org/W4389478900","https://openalex.org/W4390827838","https://openalex.org/W4391187887","https://openalex.org/W4392139513","https://openalex.org/W4392506572","https://openalex.org/W4399533497","https://openalex.org/W4399568528","https://openalex.org/W4401358849","https://openalex.org/W4402556523","https://openalex.org/W4404392086","https://openalex.org/W4406041625","https://openalex.org/W4409849495","https://openalex.org/W4410932550","https://openalex.org/W4412081323","https://openalex.org/W4412402556","https://openalex.org/W4414534068","https://openalex.org/W4416660140","https://openalex.org/W7116716421","https://openalex.org/W7134199588"],"related_works":["https://openalex.org/W4408782017","https://openalex.org/W7212295682","https://openalex.org/W2625517799","https://openalex.org/W3128233750","https://openalex.org/W7154269836","https://openalex.org/W4415351703","https://openalex.org/W2494229447","https://openalex.org/W2999502205","https://openalex.org/W7131637225","https://openalex.org/W4411533407"],"abstract_inverted_index":{"Parkinson\u2019s":[0],"disease":[1,33,114],"(PD)":[2],"is":[3,30,206],"a":[4,31,89,288],"progressive":[5],"neurodegenerative":[6],"disorder":[7,90],"most":[8],"associated":[9],"with":[10],"degeneration":[11],"of":[12,91,246,259,296],"dopaminergic":[13],"neurons":[14],"in":[15,34,178,192,262,291],"the":[16,84,139,182,257],"substantia":[17],"nigra":[18],"pars":[19],"compacta.":[20],"Increasing":[21],"clinical":[22],"and":[23,39,45,56,61,112,118,142,170,211,220,227,253,281,301],"experimental":[24,179],"evidence,":[25],"however,":[26],"indicates":[27],"that":[28,86,109,165,184,244],"PD":[29,87,193,293],"multisystem":[32],"which":[35,205,292],"immune,":[36],"metabolic,":[37],"vascular,":[38],"peripheral":[40,113,302],"nervous":[41],"system":[42],"dysfunction":[43],"precede":[44],"shape":[46],"motor":[47,68],"circuit":[48],"failure.":[49],"Nonmotor":[50],"manifestations,":[51],"including":[52,116],"olfactory":[53],"impairment,":[54],"sleep":[55],"autonomic":[57],"disturbances,":[58],"gastrointestinal":[59],"dysfunction,":[60,199],"cognitive":[62],"decline,":[63],"often":[64],"arise":[65],"years":[66],"before":[67],"diagnosis,":[69],"highlighting":[70],"pathogenic":[71],"mechanisms":[72],"beyond":[73,311],"dopamine":[74,313],"deficiency":[75],"alone.":[76],"In":[77,214],"this":[78,160],"review,":[79],"we":[80,266],"synthesize":[81],"evidence":[82,157],"supporting":[83],"view":[85],"represents":[88],"chronic":[92],"immunometabolic":[93,185,275,297],"dysregulation":[94],"rather":[95],"than":[96],"isolated":[97],"neuronal":[98,282],"loss.":[99],"We":[100],"focus":[101],"on":[102],"underestimated":[103],"but":[104],"high\u2010impact":[105],"immunological":[106],"control":[107,298],"points":[108],"integrate":[110],"central":[111],"mechanisms,":[115],"environmental":[117],"microbial":[119],"immune":[120,133,135,231,239,260],"priming,":[121],"gut\u2013brain":[122],"axis":[123],"interactions,":[124],"platelet\u2010mediated":[125],"inflammatory":[126],"signaling,":[127],"amyloid\u2010\u03b2":[128],"(A\u03b2)":[129],"as":[130,162,272],"an":[131,273],"innate":[132],"peptide,":[134],"checkpoint":[136,240],"regulation":[137],"via":[138],"PD\u20101/PD\u2010L1":[140,247],"axis,":[141],"nicotinamide":[143,152],"adenine":[144],"dinucleotide":[145],"(NAD":[146],"+":[147,270],")":[148],"homeostasis":[149],"governed":[150],"by":[151,201],"phosphoribosyltransferase":[153],"(NAMPT).":[154],"Recent":[155],"pharmacological":[156],"further":[158],"supports":[159],"framework,":[161],"metabolic":[163,212],"interventions":[164],"improve":[166],"systemic":[167,230],"energy":[168,278],"balance":[169],"reduce":[171],"inflammation":[172,219],"have":[173],"also":[174],"demonstrated":[175],"neuroprotective":[176],"effects":[177],"models,":[180],"reinforcing":[181],"concept":[183],"pathways":[186],"are":[187],"therapeutically":[188],"actionable.":[189],"Motor":[190],"impairment":[191],"arises":[194],"from":[195,238],"basal":[196],"ganglia":[197],"network":[198],"accompanied":[200],"pathological":[202],"beta\u2010band":[203],"synchronization,":[204],"increasingly":[207],"linked":[208],"to":[209,233,251],"neuroinflammation":[210],"stress.":[213],"parallel,":[215],"platelet":[216],"activation":[217,232],"during":[218],"vascular":[221],"injury":[222],"releases":[223],"amyloid":[224],"precursor":[225],"protein":[226],"A\u03b2,":[228],"linking":[229],"neurovascular":[234],"signaling.":[235],"Clinical":[236],"observations":[237],"inhibitor":[241],"therapy":[242],"demonstrate":[243],"disruption":[245],"signaling":[248],"can":[249],"lead":[250],"Parkinsonism":[252],"neuroinflammatory":[254],"syndromes,":[255],"underscoring":[256],"importance":[258],"restraint":[261],"neural":[263,300],"homeostasis.":[264],"Finally,":[265],"highlight":[267],"NAMPT\u2010dependent":[268],"NAD":[269],"salvage":[271],"important":[274],"hub":[276],"integrating":[277],"metabolism,":[279],"inflammation,":[280],"survival.":[283],"Together,":[284],"these":[285],"findings":[286],"support":[287],"unifying":[289],"framework":[290],"reflects":[294],"failure":[295],"across":[299],"systems,":[303],"suggesting":[304],"new":[305],"avenues":[306],"for":[307],"disease\u2010modifying":[308],"therapeutic":[309],"strategies":[310],"symptomatic":[312],"replacement.":[314]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2026-08-19T00:00:00"}
